Press Releases

Gilead Sciences to Present at Two Upcoming Investor Conferences

- William Blair 29th Annual Growth Stock Conference on June 9th -

FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun. 2, 2009-- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the company will be webcasting its corporate presentation at two upcoming investor conferences: the William Blair 29th Annual Growth Stock Conference in Chicago and the Goldman Sachs 30th Annual Global Healthcare Conference in New York.

Kevin Young, Gilead’s Executive Vice President of Commercial Operations, will provide an overview of the company at the William Blair conference on Tuesday, June 9 at 3:10 p.m. CDT (4:10 p.m. EDT).

John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will provide an overview of the company at the Goldman Sachs conference on Thursday, June 11 at 10:20 a.m. EDT.

To access the live webcasts via the internet log on to Please connect to the company’s website at least 15 minutes prior to each live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Source: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investor Relations)